Key Points
- Major shareholder sale: De Depot Et Placement Caisse sold 3,500,000 shares of Zevia (NYSE:ZVIA) on Jan. 27 at an average of $2.00 for a $7,000,000 transaction, reducing its position by 20.53% to 13,550,428 shares (worth about $27.1M).
- Stock and fundamentals: ZVIA opened at $1.90 and trades in a one‑year range of $1.65–$4.51 with a market cap near $142M, and the company remains unprofitable (P/E -8.61, negative ROE and net margin).
- Analyst and ownership backdrop: Coverage is mixed (three Buys, two Holds, one Sell) with a MarketBeat consensus of "Hold" and a $4.68 price target; analysts forecast -0.32 EPS for the year and institutional investors hold about 53% of the stock.
Zevia PBC (NYSE:ZVIA - Get Free Report) major shareholder De Depot Et Placement Caisse sold 3,500,000 shares of the company's stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $2.00, for a total transaction of $7,000,000.00. Following the completion of the transaction, the insider owned 13,550,428 shares of the company's stock, valued at $27,100,856. This represents a 20.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
Zevia PBC Stock Performance
ZVIA opened at $1.90 on Thursday. The business's 50-day simple moving average is $2.30 and its 200-day simple moving average is $2.56. Zevia PBC has a one year low of $1.65 and a one year high of $4.51. The stock has a market capitalization of $142.13 million, a P/E ratio of -8.61 and a beta of 0.87.
Zevia PBC (NYSE:ZVIA - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.02. Zevia PBC had a negative return on equity of 30.61% and a negative net margin of 8.83%.The company had revenue of $40.84 million for the quarter, compared to analyst estimates of $39.33 million. On average, equities research analysts forecast that Zevia PBC will post -0.32 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of Zevia PBC in a research note on Wednesday, January 21st. Craig Hallum began coverage on shares of Zevia PBC in a research note on Thursday, January 15th. They set a "buy" rating and a $4.00 target price for the company. Zacks Research lowered Zevia PBC from a "strong-buy" rating to a "hold" rating in a report on Wednesday, November 5th. Finally, Telsey Advisory Group restated an "outperform" rating and issued a $6.00 price target on shares of Zevia PBC in a research report on Wednesday, January 14th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $4.68.
Get Our Latest Analysis on Zevia PBC
Institutional Investors Weigh In On Zevia PBC
Hedge funds have recently added to or reduced their stakes in the company. TD Waterhouse Canada Inc. increased its position in Zevia PBC by 6.7% during the 4th quarter. TD Waterhouse Canada Inc. now owns 131,042 shares of the company's stock worth $303,000 after purchasing an additional 8,237 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Zevia PBC in the 4th quarter valued at approximately $27,000. SG Americas Securities LLC purchased a new stake in shares of Zevia PBC in the fourth quarter valued at approximately $31,000. CIBC Bancorp USA Inc. purchased a new stake in shares of Zevia PBC in the third quarter valued at approximately $491,000. Finally, Qube Research & Technologies Ltd acquired a new position in Zevia PBC during the third quarter worth $323,000. Institutional investors and hedge funds own 53.21% of the company's stock.
Zevia PBC Company Profile
(
Get Free Report)
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia's mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company's product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
